Preliminary report of the toxicity of Lippia junelliana (Lamiales: Verbenaceae) and Elionorus muticus (Poales: Poaceae) on Apis mellifera (Hymenoptera: Apidae)

Several phytochemicals, such as extracts and essential oils, are among the ecological alternatives that have been studied for the control of pathogens that affect humans, animals, and plants. Essential oils are aromatic oily liquids obtained from plant material and their use to control pathogens is widespread. However, they can have adverse effects when taken in high concentrations. The aim of this study was to evaluate the survival and palatability of a balanced-energy protein diet with the addition of two essential oils, Lippia junelliana (Mold.) Tronc. and Elionorus muticus (Spreng.) Kuntze, in newly hatched worker bees (Apis mellifera L.) during a period of 15 days. Consumption and number of live bees were measured daily for each treatment. For L. junelliana, our results showed a non-toxic trend in long-term survival trials (15 days) at low concentrations. In the case of E. muticus, a toxic effect with low survival was observed at all concentrations. Both essential oils showed good palatability, even at toxic levels. Our results allow us to propose the use of L. junelliana essential oil in field experiments of A. mellifera hives.Instituto de Recursos BiológicosFil: Vega, Maricel. Universidad Nacional de La Plata. Facultad de Ciencias Agrarias y Forestales. Curso de Producción Animal; ArgentinaFil: Vega, Maricel. Universidad Nacional de La Plata. Facultad de Ciencias Veterinarias. Laboratorio de Virología (LAVIR); ArgentinaFil: Reynaldi, Francisco J. Universidad Nacional de La Plata. Facultad de Ciencias Veterinarias. Laboratorio de Virología (LAVIR); ArgentinaFil: Reynaldi, Francisco J. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Altamirano, Rodrigo. Universidad Nacional de La Plata. Facultad de Ciencias Agrarias y Forestales. Curso de Cálculo Estadístico y Biometría; ArgentinaFil: Salina, Marcos D. Universidad Nacional de La Plata. Facultad de Ciencias Veterinarias. Laboratorio de Virología (LAVIR); ArgentinaFil: Salina, Marcos D. Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación; ArgentinaFil: Juarez, Miguel Angel. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Recursos Biológicos; ArgentinaAlbo, Graciela N. Universidad Nacional de La Plata. Facultad de Ciencias Agrarias y Forestales. Curso de Producción Animal; Argentin

Birthweight of babies born to migrant mothers - What role do integration policies play?

Birthweights of babies born to migrant women are generally lower than those of babies born to native-born women. Favourable integration policies may improve migrants’ living conditions and contribute to higher birthweights. We aimed to explore associations between integration policies, captured by the Migrant Integration Policy Index (MIPEX), with offspring birthweight among migrants from various world regions. In this cross-country study we pooled 31 million term birth records between 1998 and 2014 from ten high-income countries: Australia, Belgium, Canada, Denmark, Finland, Japan, Norway, Spain, Sweden and United Kingdom (Scotland). Birthweight differences in grams (g) were analysed with regression analysis for aggregate data and random effects models. Proportion of births to migrant women varied from 2% in Japan to 28% in Australia. The MIPEX score was not associated with birthweight in most migrant groups, but was positively associated among native-born (mean birthweight difference associated with a 10-unit increase in MIPEX: 105 g; 95% CI: 24, 186). Birthweight among migrants was highest in the Nordic countries and lowest in Japan and Belgium. Migrants from a given origin had heavier newborns in countries where the mean birthweight of native-born was higher and vice versa. Mean birthweight differences between migrants from the same origin and the native-born varied substantially across destinations (70 g–285 g). Birthweight among migrants does not correlate with MIPEX scores. However, birthweight of migrant groups aligned better with that of the native-born in destination counties. Further studies may clarify which broader social policies support migrant women and have impacts on perinatal outcomes.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Clinical Outcomes of Thirteen Patients with Acute Chagas Disease Acquired through Oral Transmission from Two Urban Outbreaks in Northeastern Brazil

Chagas disease is caused by a parasitic protozoan transmitted to humans by the contaminated feces of blood-feeding assassin bugs from the Triatominae subfamily. It may also be transmitted from mother to baby during pregnancy, by breastfeeding, blood transfusion or organ transplant. In rare cases, the disease can also be caused by accidental ingestion of contaminated food (sugar cane or açaí juice, drinking water, etc.). Acute Chagas disease often presents itself as a mononucleosis-like syndrome, with symptoms including fever, lymph node enlargement and muscle pain. The mortality rate of acute Chagas disease is high, mainly due to heart failure as a consequence of cardiac fiber lesions. There are few studies describing clinical outcomes and the disease progression of patients who receive therapeutic treatment, especially with regard to cardiac exam findings. In this report, the authors describe clinical findings from two micro-outbreaks occurring in impoverished towns in northeastern Brazil. Prior to receiving treatment, patient mortality rate was 28.6% in one of the outbreaks, and one pregnant woman experienced a spontaneous abortion due to the disease in the other outbreak. Most patients complained of fever, dyspnea, myalgia and periorbital edema. After receiving a two-month course of treatment, clinical symptoms improved and the number of abnormalities in cardiac exams decreased

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research